Key metrics and charts across all fundamental categories.
Stock price and market valuation
HBAN trades at $17.58, a 17.1% increase year-over-year. Market capitalization stands at $32.86B, up 50.5% from the prior year. Track HBAN price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$21.98B in TTM revenue grew 11.7% YoY, reaching $6.29B last quarter. TTM EBITDA of $2.68B on operating income of $641.00M shows growth is flowing through. Net income of $2.21B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $285.37B in assets and $21.59B in long-term debt, the D/E of 0.7 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 14.9x P/E, the stock trades below market averages — potentially undervalued. P/S of 1.5x and P/B of 1.0x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 10.2% is down 3.2% YoY — costs are rising relative to revenue. Net margin at 8.3% and gross margin of 62.0%. ROE of 6.8% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $400.00M on $524.00M in operating cash flow. The FCF / Net Income ratio of 0.2x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $2.10B provide financial flexibility. Shares outstanding rose 28.5% YoY — shareholder dilution is eroding per-share value.
